(Q43991963)

English

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up results and analysis of prognostic factors (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

phase III clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Mitsune Tanimoto

10

object named as

Mitsune Tanimoto

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Katsuyuki Kiura

3

object named as

Katsuyuki Kiura

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

object named as

Hiroshi Ueoka

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tomonori Moritaka

7

object named as

Tomonori Moritaka

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

5

object named as

Nagio Takigawa

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

9

object named as

Mine Harada

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Yoshihiko Segawa

6

object named as

Yoshihiko Segawa

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Shunkichi Hiraki

8

object named as

Shunkichi Hiraki

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tsuyoshi Kodani

1

object named as

Tsuyoshi Kodani

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

author name string

Masahiro Tabata

4

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

36

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

313-319

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized study of cisplatin versus cisplatin plus vindesine for non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung cancer: a study of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of five cisplatin-containing treatments in patients with metastatic non-small-cell lung cancer: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination chemotherapy with vindesine-ifosfamide-cisplatin (VIP) in locally advanced unresectable stage III and in stage IV non-small cell lung cancer: a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomised trial of two cisplatin-containing chemotherapy regimens in patients with Stage III-B and IV non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical characterization of non-small-cell lung cancer tumors showing neuroendocrine differentiation features

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2802%2900008-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(02)00008-9

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43991963&oldid=2105386056"